UK markets closed

C4 Therapeutics, Inc. (CCCC)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
5.64-0.32 (-5.44%)
As of 03:33PM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts6677
Avg. Estimate-0.37-0.38-1.52-1.75
Low estimate-0.46-0.48-1.91-3.01
High estimate-0.18-0.27-1.01-1.35
Year ago EPS-0.73-0.55-2.65-1.52
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts6576
Avg. Estimate4.78M7.48M25.69M16.86M
Low estimateN/AN/A3MN/A
High estimate10M17.4M46M30M
Year ago sales2.66M5.46M20.76M25.69M
Sales growth (year/est)79.40%37.00%23.80%-34.40%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-0.69-0.66-0.68-0.35
Actual EPS-0.73-0.55-0.7-0.41
Difference-0.040.11-0.02-0.06
Surprise %-5.80%16.70%-2.90%-17.10%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-0.37-0.38-1.52-1.75
7 days ago-0.39-0.37-1.62-1.73
30 days ago-0.5-0.49-1.85-1.92
60 days ago-0.5-0.49-1.85-1.92
90 days ago-0.56-0.49-2.36-2.76
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 days1111
Up last 30 days6665
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesCCCCIndustrySector(s)S&P 500
Current qtr.49.30%N/AN/AN/A
Next qtr.30.90%N/AN/AN/A
Current year42.60%N/AN/AN/A
Next year-15.10%N/AN/AN/A
Next 5 years (per annum)22.30%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A